Skip to main content
Premium Trial:

Request an Annual Quote

PGx Startup AssureRx Receives VC Funding from Cincinnati Investors

NEW YORK (GenomeWeb News) — Pharmacogenomics company AssureRx said today it has received a round of funding led by Cincinnati-area investors. The company did not disclose the amount of financing it received.
 
Investors in the round include Queen City Angels, Cincy Tech USA, the Health Foundation of Greater Cincinnati, Blue Chip Venture Company, Cincinnati Children’s Tomorrow Fund, and individual investors.
 
The company, which was spun out of the Cincinnati Children’s Hospital Medical Center and Mayo Clinic, is focused on non-invasive, predictive pharmacogenetic tests that measure, analyze, and interpret genes of patients with neuropsychiatric disorders. 
 
The company said its test translates data for doctors within 48 hours after it receives a sample from a patient.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.